BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong X, Su H, Jiang F, Li H, Shi G, Fan L. miR-133a, directly targeted USP39, suppresses cell proliferation and predicts prognosis of gastric cancer. Oncol Lett 2018;15:8311-8. [PMID: 29805563 DOI: 10.3892/ol.2018.8421] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Hua YT, Xu WX, Li H, Xia M. Emerging roles of MiR-133a in human cancers. J Cancer 2021;12:198-206. [PMID: 33391416 DOI: 10.7150/jca.48769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yuan J, Zhang G, Li X, Ma Q, Cheng W, Wang W, Zhang B, Hu T, Song G. Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway. Int J Mol Sci 2020;21:E8949. [PMID: 33255748 DOI: 10.3390/ijms21238949] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kuligina ES, Sokolenko AP, Bizin IV, Romanko AA, Zagorodnev KA, Anisimova MO, Krylova DD, Anisimova EI, Mantseva MA, Varma AK, Hasan SK, Ni VI, Koloskov AV, Suspitsin EN, Venina AR, Aleksakhina SN, Sokolova TN, Milanović AM, Schürmann P, Prokofyeva DS, Bermisheva MA, Khusnutdinova EK, Bogdanova N, Dörk T, Imyanitov EN. Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39. Breast Cancer Res Treat 2020;179:731-42. [DOI: 10.1007/s10549-019-05492-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Shen Y, Chen F, Liang Y. MicroRNA-133a inhibits the proliferation of non-small cell lung cancer by targeting YES1. Oncol Lett 2019;18:6759-65. [PMID: 31807185 DOI: 10.3892/ol.2019.11030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sun J, Shi X, Mamun MAA, Gao Y. The role of deubiquitinating enzymes in gastric cancer. Oncol Lett 2020;19:30-44. [PMID: 31897112 DOI: 10.3892/ol.2019.11062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shen Y, Kang A, Wang M. MiR-133a suppressed cell migration and invasion by targeting SOX4 in non-small cell lung cancer. Panminerva Med 2020;62. [DOI: 10.23736/s0031-0808.19.03646-2] [Reference Citation Analysis]
7 Wang S, Wang Z, Li J, Qin J, Song J, Li Y, Zhao L, Zhang X, Guo H, Shao C, Kong B, Liu Z. Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2. Cell Death Dis 2021;12:294. [PMID: 33731694 DOI: 10.1038/s41419-021-03581-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cheng Y, Wang Y, Cheng Y, Yang Q, Zhang L, Li Z, Cheng J. FOXD3-induced miR-133a blocks progression and metastasis of colorectal cancer through regulating UBA2. J Cancer 2021;12:6145-54. [PMID: 34539887 DOI: 10.7150/jca.60647] [Reference Citation Analysis]